Hoch, M., D'Ambrosio, D., Wilbraham, D., Brossard, P., & Dingemanse, J. (2013). Oc015—Up-Titration Study With Ponesimod, A Selective S1p1 Receptor Modulator, To Assess Its Maximum Tolerated Dose In Healthy Subjects. Clinical therapeutics, 35(8), e6-e7. https://doi.org/10.1016/j.clinthera.2013.07.014
Chicago Style (17th ed.) CitationHoch, M., D. D'Ambrosio, D. Wilbraham, P. Brossard, and J. Dingemanse. "Oc015—Up-Titration Study With Ponesimod, A Selective S1p1 Receptor Modulator, To Assess Its Maximum Tolerated Dose In Healthy Subjects." Clinical Therapeutics 35, no. 8 (2013): e6-e7. https://doi.org/10.1016/j.clinthera.2013.07.014.
MLA (9th ed.) CitationHoch, M., et al. "Oc015—Up-Titration Study With Ponesimod, A Selective S1p1 Receptor Modulator, To Assess Its Maximum Tolerated Dose In Healthy Subjects." Clinical Therapeutics, vol. 35, no. 8, 2013, pp. e6-e7, https://doi.org/10.1016/j.clinthera.2013.07.014.